PL2611906T3 - Ogólnoustrojowe terapie allogenicznymi komórkami macierzystymi do leczenia chorób u kotów i psów - Google Patents
Ogólnoustrojowe terapie allogenicznymi komórkami macierzystymi do leczenia chorób u kotów i psówInfo
- Publication number
- PL2611906T3 PL2611906T3 PL11822565.5T PL11822565T PL2611906T3 PL 2611906 T3 PL2611906 T3 PL 2611906T3 PL 11822565 T PL11822565 T PL 11822565T PL 2611906 T3 PL2611906 T3 PL 2611906T3
- Authority
- PL
- Poland
- Prior art keywords
- cats
- dogs
- systemic
- diseases
- treatment
- Prior art date
Links
- 241000282472 Canis lupus familiaris Species 0.000 title 1
- 241000282326 Felis catus Species 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000009168 stem cell therapy Methods 0.000 title 1
- 230000009885 systemic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pulmonology (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Inorganic Chemistry (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37845710P | 2010-08-31 | 2010-08-31 | |
PCT/US2011/049977 WO2012030968A1 (en) | 2010-08-31 | 2011-08-31 | Systemic, allogenic stem cell therapies for treatment of diseases in animals |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2611906T3 true PL2611906T3 (pl) | 2024-05-27 |
Family
ID=45697573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11822565.5T PL2611906T3 (pl) | 2010-08-31 | 2011-08-31 | Ogólnoustrojowe terapie allogenicznymi komórkami macierzystymi do leczenia chorób u kotów i psów |
Country Status (11)
Country | Link |
---|---|
US (6) | US20120052049A1 (pl) |
EP (1) | EP2611906B1 (pl) |
JP (2) | JP2013536860A (pl) |
CN (1) | CN103180435A (pl) |
AU (1) | AU2011295954B2 (pl) |
BR (1) | BR112013004917A2 (pl) |
CA (1) | CA2809272A1 (pl) |
DK (1) | DK2611906T3 (pl) |
PL (1) | PL2611906T3 (pl) |
PT (1) | PT2611906T (pl) |
WO (1) | WO2012030968A1 (pl) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9453202B2 (en) | 2003-10-08 | 2016-09-27 | Vet-Stem, Inc. | Methods of preparing and using novel stem cell compositions and kits comprising the same |
EP2624846A2 (en) * | 2010-10-08 | 2013-08-14 | Osiris Therapeutics, Inc. | Nanoparticle-loaded cells |
US10080558B2 (en) | 2013-02-27 | 2018-09-25 | Med Invent Devices Private Limited | Device providing enlargement and preventing collapse of the pupil of the eye |
US20140314872A1 (en) * | 2013-04-22 | 2014-10-23 | Hans Klingemann | Methods of Use of Culture Supernatant Obtained from Mesenchymal Stem Cells from Dogs and Cats for Treatment of Organ Dysfunction |
WO2015023901A1 (en) * | 2013-08-15 | 2015-02-19 | The Regents Of The University Of California | Placenta-derived multipotent stem cells |
CN114392274A (zh) | 2013-08-27 | 2022-04-26 | 库克通用生物技术有限责任公司 | 可来源于血小板浓缩液的生物活性组合物及其制备和使用方法 |
EA024138B1 (ru) * | 2013-10-17 | 2016-08-31 | Акционерное Общество "Научный Центр Урологии Имени Академика Б.У. Джарбусынова" | Способ проведения клеточной терапии для лечения экспериментального хронического орхоэпидидимита |
EA025096B1 (ru) * | 2013-10-17 | 2016-11-30 | Акционерное Общество "Научный Центр Урологии Имени Академика Б.У. Джарбусынова" | Способ проведения клеточной терапии для лечения экспериментального хронического орхоэпидидимита |
US10801014B2 (en) * | 2013-12-06 | 2020-10-13 | Global Stem Cell Technology | Method and composition for inducing chondrogenesis or tenogenesis in mesenchymal stem cells |
ES2846760T3 (es) * | 2013-12-19 | 2021-07-29 | Univ Liege | Células madre derivadas de músculo de mamífero |
EP3102124A1 (en) * | 2014-02-06 | 2016-12-14 | Stryker European Holdings I, LLC | Bone marrow harvesting and storage |
US10918669B2 (en) | 2014-07-25 | 2021-02-16 | Recellerate, Inc. | Methods of treating exercise-induced pulmonary hemorrhage |
AU2015339886B2 (en) * | 2014-09-29 | 2019-05-09 | Cook General Biotechnology Llc | Uses of trehalose in cell suspensions |
MA40996A (fr) * | 2014-11-17 | 2017-09-26 | Univ Miami | Matériaux et procédés de traitement d'un dysfonctionnement endothélial et procédés de surveillance de l'efficacité du traitement chez un patient |
CN107257687B (zh) * | 2014-12-23 | 2021-12-03 | 迈索布拉斯特国际有限公司 | 用于治疗心力衰竭的方法 |
US10342830B2 (en) | 2015-01-05 | 2019-07-09 | Gary M. Petrucci | Methods and materials for treating lung disorders |
EP3273881B1 (en) | 2015-03-24 | 2019-10-09 | Stryker European Holdings I, LLC | Bone marrow harvesting device |
JP7057557B2 (ja) * | 2015-07-31 | 2022-04-20 | 国立大学法人大阪大学 | 上皮疾患に対する治療及び/又は予防有効性を評価する方法、上皮疾患治療剤のスクリーニング方法、及び上皮疾患治療剤 |
KR20180043834A (ko) * | 2015-09-08 | 2018-04-30 | 셀 아이디어스 피티와이 엘티디 | 세포 신장 방법들 및 치료 조성물들 |
US11149249B2 (en) * | 2015-09-25 | 2021-10-19 | Mitsubishi Gas Chemical Company, Inc. | Base material for cell culture and cell culture method using same, cell culture container, and use as base material |
CN106085954A (zh) * | 2016-06-24 | 2016-11-09 | 安徽未名细胞治疗有限公司 | 一种大量人外周血pbmc快速分离方法 |
CN106265744A (zh) * | 2016-09-29 | 2017-01-04 | 广州赛莱拉干细胞科技股份有限公司 | 脐带间充质干细胞在制备治疗角膜损伤的干细胞制剂中的应用 |
AU2017358042A1 (en) * | 2016-11-11 | 2019-05-30 | Longeveron Inc. | Methods of using human mesenchymal stem cells to effect cellular and humoral immunity |
US10478531B2 (en) | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
WO2019158712A1 (en) * | 2018-02-16 | 2019-08-22 | Nextcell Pharma Ab | Allogeneic composition |
WO2019238952A1 (en) * | 2018-06-15 | 2019-12-19 | Marinas Pardo Luis | Pharmaceutical composition for dermatology and uses thereof |
CN109432128A (zh) * | 2018-12-07 | 2019-03-08 | 卡替(上海)生物技术股份有限公司 | 牙髓间充质干细胞在银屑病治疗中的应用 |
CN109370986A (zh) * | 2018-12-11 | 2019-02-22 | 南京农业大学 | 一种犬脂肪干细胞的提取方法及其制剂和应用 |
US20220280570A1 (en) * | 2019-01-11 | 2022-09-08 | Vetbiobank | Stromal cells derived from neonatal felines and uses thereof |
US11697799B2 (en) | 2019-04-15 | 2023-07-11 | Ossium Health, Inc. | System and method for extraction and cryopreservation of bone marrow |
CN112941021A (zh) * | 2020-03-13 | 2021-06-11 | 深圳市第二人民医院(深圳市转化医学研究院) | 一种骨关节炎关节液来源的间充质干细胞的培养方法 |
EP4181675A4 (en) | 2020-07-18 | 2024-04-24 | Ossium Health Inc | PERMEATION OF WHOLE VERTEBRAL BODY WITH CRYOPROTECTIVE USING VACUUM-ASSISTED DIFFUSION |
EP4228406A1 (en) | 2020-10-14 | 2023-08-23 | Ossium Health, Inc. | Systems and methods for extraction and cryopreservation of bone marrow |
CN117279650A (zh) | 2020-12-18 | 2023-12-22 | 奥瑟姆健康公司 | 细胞治疗方法 |
CN117015406A (zh) * | 2021-01-19 | 2023-11-07 | 嘉兰宠物有限公司 | 用于针对临床应用优化生殖组织衍生细胞产量和活力的方法 |
BR112023024125A2 (pt) * | 2021-05-21 | 2024-01-30 | Daewoong Pharmaceutical Co Ltd | Uso de uma composição farmacêutica |
AU2022307748A1 (en) * | 2021-07-08 | 2024-01-25 | Boehringer Ingelheim Veterinary Medicine Belgium | Mesenchymal stem cells for use in the treatment of osteoarthritis in animals |
Family Cites Families (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5837539A (en) * | 1990-11-16 | 1998-11-17 | Osiris Therapeutics, Inc. | Monoclonal antibodies for human mesenchymal stem cells |
US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5550127A (en) * | 1995-09-07 | 1996-08-27 | Pantano; James A. | Method of treatment for eiph in racing stock |
EP1062321B1 (en) * | 1998-03-13 | 2004-12-29 | Osiris Therapeutics, Inc. | Uses for humane non-autologous mesenchymal stem cells |
CA2405345C (en) * | 2000-04-25 | 2012-09-18 | Osiris Therapeutics, Inc. | Joint repair using mesenchymal stem cells |
ATE482725T1 (de) * | 2003-04-01 | 2010-10-15 | Us Dept Of Veteran S Affaires | Auf stammzellen, vorläuferzellen oder targetzellen basierende behandlung von multiorganversagen. |
AU2004252570C1 (en) * | 2003-06-27 | 2012-03-01 | Ethicon, Incorporated | Soft tissue repair and regeneration using postpartum-derived cells |
KR20050044849A (ko) * | 2003-11-07 | 2005-05-13 | 학교법인 인하학원 | 중간엽 줄기세포로부터 연골세포를 분화시키는 방법 |
EP3461884A1 (en) * | 2004-03-22 | 2019-04-03 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
CN1676603A (zh) * | 2004-03-30 | 2005-10-05 | 中国人民解放军军事医学科学院基础医学研究所 | 一种人骨髓间充质干细胞体外扩增的新方法 |
JP2006078034A (ja) * | 2004-09-08 | 2006-03-23 | Ntt Power & Building Facilities Inc | 室外機及び室外機の設置方法 |
JP2006123699A (ja) * | 2004-10-28 | 2006-05-18 | Miyata Ind Co Ltd | 樹脂製自転車フレーム又はその部品、及びそれらの製造方法 |
WO2006088867A2 (en) * | 2005-02-15 | 2006-08-24 | Medistem Laboratories, Incorporated | Method for expansion of stem cells |
WO2006121445A2 (en) * | 2005-05-10 | 2006-11-16 | United States Of America Department Of Veteran's Affairs | Therapy of kidney diseases and multiorgan failure with mesenchymal stem cells and mesenchymal stem cell conditioned media |
CN100344757C (zh) * | 2005-10-18 | 2007-10-24 | 天津昂赛细胞基因工程有限公司 | 人胎盘、脐带间充质干细胞库及其构建方法 |
US20070253931A1 (en) * | 2006-01-12 | 2007-11-01 | Osiris Therapeutics, Inc. | Use of mesenchymal stem cells for treating genetic diseases and disorders |
MX2008012085A (es) * | 2006-03-23 | 2009-01-22 | Pluristem Ltd | Metodos para expansion de celulas y usos de celulas y medios acondicionados producidos de esta manera para terapia. |
US7724211B2 (en) * | 2006-03-29 | 2010-05-25 | Nvidia Corporation | System, method, and computer program product for controlling stereo glasses shutters |
JP2010500047A (ja) * | 2006-08-15 | 2010-01-07 | エージェンシー フォー サイエンス,テクノロジー アンド リサーチ | 間葉系幹細胞馴化培地 |
US7947435B2 (en) * | 2007-01-19 | 2011-05-24 | Seoul National University Industry Foundation | Neuronal regeneration material screening method by ex vivo model |
JP4926872B2 (ja) * | 2007-07-27 | 2012-05-09 | シャープ株式会社 | イオン発生素子の製造方法、イオン発生素子、帯電装置および画像形成装置 |
US20110262402A1 (en) * | 2007-09-07 | 2011-10-27 | Masahiko Kuroda | Therapeutic and prophylactic agents for arthritis |
US20090214484A1 (en) * | 2008-02-22 | 2009-08-27 | Nikolay Mironov | Stem cell therapy for the treatment of central nervous system disorders |
US8318485B2 (en) * | 2008-02-25 | 2012-11-27 | Natalie Gavrilova | Stem cell therapy for the treatment of diabetic retinopathy and diabetic optic neuropathy |
JP5541845B2 (ja) * | 2008-03-28 | 2014-07-09 | Jcrファーマ株式会社 | アトピー性皮膚炎治療剤 |
US20130164267A1 (en) * | 2008-06-11 | 2013-06-27 | Cell4Vet Corporation | Adipose tissue-derived stem cells for veterinary use |
EP2186883A1 (en) * | 2008-11-04 | 2010-05-19 | Fresenius Medical Care | An isolated multipotent mesenchymal stem cell from human adult glomeruli (hGL-MSC), a method of preparing thereof and uses thereof in the regenerative medicine of the kidney |
US20110305673A1 (en) * | 2008-11-12 | 2011-12-15 | The University Of Vermont And State Agriculture College | Compositions and methods for tissue repair |
CA2744423A1 (en) * | 2008-11-20 | 2010-05-27 | Diaz Arroyo, Manuel | Myometrial-derived mesenchymal stem cells |
US20100297094A1 (en) * | 2009-01-30 | 2010-11-25 | Harlan John M | Therapy or prevention of diseases with cells or cell supernatant |
EP2446024A1 (en) * | 2009-06-26 | 2012-05-02 | Life&Light Limited | Mesenchymal stem cells grown under hypoxic conditions: compositions, methods and uses therefor |
US20120201791A1 (en) * | 2009-10-15 | 2012-08-09 | Tai June Yoo | Methods of treating diseases or conditions using mesenchymal stem cells |
-
2011
- 2011-08-31 PL PL11822565.5T patent/PL2611906T3/pl unknown
- 2011-08-31 JP JP2013527268A patent/JP2013536860A/ja active Pending
- 2011-08-31 BR BR112013004917A patent/BR112013004917A2/pt not_active Application Discontinuation
- 2011-08-31 WO PCT/US2011/049977 patent/WO2012030968A1/en active Application Filing
- 2011-08-31 PT PT118225655T patent/PT2611906T/pt unknown
- 2011-08-31 AU AU2011295954A patent/AU2011295954B2/en active Active
- 2011-08-31 CN CN2011800515534A patent/CN103180435A/zh active Pending
- 2011-08-31 CA CA2809272A patent/CA2809272A1/en active Pending
- 2011-08-31 US US13/222,681 patent/US20120052049A1/en not_active Abandoned
- 2011-08-31 EP EP11822565.5A patent/EP2611906B1/en active Active
- 2011-08-31 DK DK11822565.5T patent/DK2611906T3/da active
-
2012
- 2012-07-03 US US13/541,330 patent/US20120269785A1/en not_active Abandoned
- 2012-07-03 US US13/541,366 patent/US20120269787A1/en not_active Abandoned
- 2012-07-03 US US13/541,347 patent/US20120269786A1/en not_active Abandoned
-
2016
- 2016-06-02 JP JP2016111034A patent/JP2016185972A/ja active Pending
- 2016-09-30 US US15/281,291 patent/US20170014454A1/en not_active Abandoned
-
2021
- 2021-05-11 US US17/302,747 patent/US20220096558A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20120269787A1 (en) | 2012-10-25 |
US20220096558A1 (en) | 2022-03-31 |
JP2013536860A (ja) | 2013-09-26 |
US20120052049A1 (en) | 2012-03-01 |
EP2611906A4 (en) | 2014-03-19 |
US20120269785A1 (en) | 2012-10-25 |
PT2611906T (pt) | 2024-04-16 |
US20170014454A1 (en) | 2017-01-19 |
CA2809272A1 (en) | 2012-03-08 |
EP2611906A1 (en) | 2013-07-10 |
DK2611906T3 (da) | 2024-04-08 |
CN103180435A (zh) | 2013-06-26 |
JP2016185972A (ja) | 2016-10-27 |
AU2011295954A1 (en) | 2013-04-11 |
WO2012030968A1 (en) | 2012-03-08 |
AU2011295954B2 (en) | 2015-08-13 |
EP2611906B1 (en) | 2024-01-03 |
BR112013004917A2 (pt) | 2016-09-20 |
US20120269786A1 (en) | 2012-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2611906T3 (pl) | Ogólnoustrojowe terapie allogenicznymi komórkami macierzystymi do leczenia chorób u kotów i psów | |
HK1259279A1 (zh) | 用於細胞封裝和細胞治療的改性藻朊酸鹽 | |
EP2723263A4 (en) | SYSTEMS, DEVICES, AND METHODS FOR INDUCING PROGRAMMED CELL DEATH OF ADIPOSE TISSUES | |
EP2908864A4 (en) | SYSTEM FOR THE DELIVERY OF THERAPEUTICS IN LIVING CELLS AND CELLS | |
IL220040A0 (en) | Methods and low dose regimens for treating red blood cell disorders | |
HK1206622A1 (en) | Formulations and methods for vaginal delivery of antiprogestins | |
EP2658556A4 (en) | METHODS OF CRYOPRESERVATION AND ENCAPSULATION OF CELLS | |
IL226127A0 (en) | A compound containing hydrolyzed proteins and an oligosaccharide for the treatment of skin diseases | |
ZA201305498B (en) | Methods and compositions suitable for managing blood glucose in animals | |
EP2627331A4 (en) | METHODS OF TREATING HYPERURICEMIA AND RELATED DISEASES | |
PL2793929T3 (pl) | Podłoże kondycjonowane uzyskane z łożyskowych mezenchymalnych komórek macierzystych w terapii stanu przedrzucawkowego | |
ZA201304147B (en) | Multipurpose gel for vaginal dryness with direct and delayed effect | |
EP2747728A4 (en) | SYSTEMS AND METHODS FOR STIMULATING CELLULAR FUNCTION IN TISSUE | |
EP2854834A4 (en) | PLANT LECTINES AS AN EXCIPIENT OF RELATED MEDICINAL SUBSTANCES IN ANIMAL AND HUMAN CELLS | |
EP2707479A4 (en) | USE OF ZSCAN4 AND ZSCAN4-DEPENDENT GENES FOR DIRECT REPROGRAMMING OF SOMATIC CELLS | |
EP2640407A4 (en) | PROCESS FOR INCREASING THE EXPRESSION AND ACTIVITY OF NEPRILYSIN | |
IL237411A0 (en) | A method for diagnosing and treating cancer that targets molecules expressed in cancer stem cells | |
IL232642A0 (en) | A method for characterizing circulating cells and its use in diagnosis | |
EP2911748A4 (en) | CANCER STEM CELL VACCINATION AND TREATMENT | |
ZA201305086B (en) | Methods and compositions useful for promoting sleep in animals | |
EP2772760A4 (en) | METHOD FOR MEASURING A BIOLOGICAL ACTIVE BIOLOGICAL ACTIVE SUBSTANCE AND MICROPARTICLE AND EXTRACT FOR USE IN THIS METHOD | |
EP2581347A4 (en) | FRESHWATER GENERATION DEVICE AND FRESHWATER GENERATING METHOD | |
PL2735235T3 (pl) | Zastosowanie kompleksu enzymatycznego w żywieniu zwierząt hodowlanych | |
GB0913102D0 (en) | Animal models and therapeutic molesules | |
GB2480696B (en) | Improvements in and relating to animal control gate assemblies |